ZCA
RETA

Zeke Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Zeke Capital Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,056
Closed -$216K – 524
2019
Q4 		$216K Buy
+1,056
New +$216K 0.02% 517